WallStSmart
ADTX

Aditxt Inc.

NASDAQ: ADTX · HEALTHCARE · BIOTECHNOLOGY

$0.00
-6.82% today

Updated 2026-07-10

Market cap
$9.48M
P/E ratio
P/S ratio
661.33x
EPS (TTM)
$-1,380.80
Dividend yield
52W range
$0 – $33,439
Volume
510.3M

Aditxt Inc. (ADTX) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item201720182019202020212022202320242025
Operating cash flow$-386263.00$-386263.00$-464352.00$-7.22M$-22.28M$-22.39M$-18.58M$-16.76M$-25.69B
Capital expenditures$170629.00$170629.00$170629.00$170629.00$1.02M$367079.00$14407.00$0.00$13.74M
Depreciation
Stock-based comp$612344.00$3.52M$4.23M$3.19M$4.64M$3.13M$1.40M$6.75M$473.31M
Free cash flow$-556892.00$-556892.00$-634981.00$-7.39M$-23.29M$-22.76M$-18.59M$-16.76M$-25.70B
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash

Frequently asked questions

What is Aditxt Inc. 's revenue?

Aditxt Inc. 's trailing twelve-month revenue is $14340.00. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is ADTX?

In its most recent fiscal year, ADTX ran a gross margin of 8.39%, an operating margin of -612,542.22%, and a net margin of -1,305,608.79%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does ADTX generate?

ADTX produced $-25.70B in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is ADTX's balance sheet healthy?

ADTX holds $3.20B in cash and equivalents against — in long-term debt, on $5.61M of shareholder equity. That debt is best read against the cash flow the business throws off each year.